Firm intentionTechnology9 November 2026

Quanome Technologies, Inc. to acquire an approximately 5% stake in QAI Labs Ltd.

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
Quanome Technologies, Inc.
Target
Approximately 5% stake in QAI Labs Ltd.
Deal value
USD 5,000,000
Announced
9 November 2026
Status
Firm intention
Sector
Technology
Country
United States
Consideration
shares
What we know

Quanome Technologies, Inc. (Nasdaq: QNME) announced on 9 November 2026 that it has agreed to take an approximately 5% stake in QAI Labs Ltd., a Delaware-based life sciences technology company with a laboratory in Sugar Land, Texas. The Stock Purchase Agreement was signed on 4 November 2026, and Quanome disclosed it in a Form 8-K and an accompanying press release on 9 November.

QAI Labs is developing NOVA-3, an AI-enabled platform designed to combine quantum-computing algorithms, run on classical simulators, with laboratory testing to advance multi-specific antibody candidates. The company holds two in-licensed programs, IMT030122 (EpCAM × CD3 × 4-1BB) and IMB030202 (EpCAM × 4-1BB × HSA), both at an early preclinical stage with no IND-enabling studies commenced. QAI Labs remains independent and will not become a subsidiary of Quanome.

The deal is all-stock. At closing, QAI Labs will issue 31,579 new shares to Quanome, about 5% of its equity immediately after the issuance. In exchange, Quanome will issue 6,541,236 new shares of its common stock to QAI Labs, equal to approximately 19% of Quanome's outstanding common stock before the issuance and approximately 15.97% after it. The parties assigned the consideration shares an aggregate negotiated transaction value of US$5.0 million, which corresponds to an implied equity valuation of approximately US$100 million for QAI Labs.

The agreement has not yet closed. Closing depends on the conditions in the Purchase Agreement, including required consents and filings, the absence of legal restraints and no material adverse change in QAI Labs' business, and, subject to certain exceptions, either party may terminate if closing has not occurred by 31 December 2026 or another date the parties agree. The Quanome shares will be issued without Securities Act registration, relying on the Section 4(a)(2) exemption, and will be subject to transfer restrictions.

Deal timeline

1 update
  1. Firm intention

    QUANOME TECHNOLOGIES, INC. firm intention to acquire QAI LABS LTD.

    Item 1.01 Entry Into a Material Definitive Agreement. Stock Purchase Agreement On November 4, 2026, QUANOME TECHNOLOGIES, INC., a company incorporated and existing under the laws of the state of Nevada (the “Buyer” or “Company”), and QAI LABS LTD., a company incorporated and existing under the laws of the state of Delaware (the “Seller”), entered into a Stock Purchase Agreement (the “Purchase Agre

    Source

For business owners

What would selling your own business involve?

Use the deal as a starting point, not a valuation benchmark. Learn the decisions behind a sale and apply them to your own preparation.

Guides are free to read. Free tools require email access; indicative results are not professional advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Technology M&A activity tracked by Exit Mode.

Buyer history

Quanome Technologies, Inc.

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive